February 24, 2016 2:28pm
Subscribe to translation of the stem, cell and gene therapy and regenerative medicine (SCGT&RM) companies actionable news and opinion layered with a forward pricing metric today ...
To access our interpretation and opinion, click here for access.
RegMed Investors’, the SCGT&RM breakdown of the content and interpretation of news gives portfolio managers, traders and salespeople an edge.
I spend 12 to 14 hours a day executing deep dives on key themes that matter most to our subscribers as volatility is fast and furious – who can wait?
Our subscription-only daily content is succinct, provocative, and unbiased insight takes you through to the “Bottom Line” of the headlines on “our” universe without the “hyperbole” noise, redundancy and chatter.
Our first, factual and fearless interpretations are widely regarded as some of the best in the business.
To access our interpretation and opinion, click here for access. Subscribe: http://www.regmedinvestors.com/create-account
For the past 6 years, my goal has been to help individual investors become better, more educated traders – with trades that can create profits, regardless of market conditions.